In a previous study, the ratio between transcripts from a set of genes enriched in cDC1 and levels of transcripts expressed by other myeloid cells proved to be a prognostic marker for cancer patient survival (Broz et al., 2014). This evidence concerns the gene MPPE1 and cancer.